ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,127.79
      1.26%
      US Tech 100
      17,446.00
      2.17%
      Dow Jones
      38,675.68
      1.18%
      Brent Oil
      82.765
      0.00%
      Bitcoin
      63,604.92
      1.14%
      Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NYSE
      6. Bausch plus Lomb Corporation (BLCO)

      7. Bausch plus Lomb Corporation (BLCO) News

      BLCO

      Bausch plus Lomb (BLCO)

      Bausch plus Lomb Corporation
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NYSE:BLCO
      DateTimeSourceHeadlineSymbolCompany
      05/01/20246:58AMBusiness WireBausch + Lomb Announces First-Quarter 2024 ResultsNYSE:BLCOBausch plus Lomb Corporation
      04/29/20247:00AMBusiness WireBausch + Lomb Announces Presentation of New Data at the Association for Research in Vision and Ophthalmology Annual MeetingNYSE:BLCOBausch plus Lomb Corporation
      04/25/20248:30AMBusiness WireBausch + Lomb Announces Statistically Significant Results From a Clinical Study of a Novel Daily Nutritional Supplement for Dry EyesNYSE:BLCOBausch plus Lomb Corporation
      04/18/20247:00AMBusiness WireBausch + Lomb Reports More Than 84 Million Units of Contact Lenses, Lens Care and Eye Care Materials Collected Through Innovative Recycling ProgramsNYSE:BLCOBausch plus Lomb Corporation
      04/15/202412:00PMBusiness WireBausch + Lomb Will Release First-Quarter 2024 Financial Results on May 1NYSE:BLCOBausch plus Lomb Corporation
      03/27/20247:00AMBusiness WireBausch + Lomb Will Present New Scientific Data and Analyses at the American Society of Cataract and Refractive Surgery Annual MeetingNYSE:BLCOBausch plus Lomb Corporation
      03/04/20245:57PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:BLCOBausch plus Lomb Corporation
      03/04/20245:54PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:BLCOBausch plus Lomb Corporation
      03/04/20245:52PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:BLCOBausch plus Lomb Corporation
      03/01/20244:45PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:BLCOBausch plus Lomb Corporation
      03/01/20244:43PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:BLCOBausch plus Lomb Corporation
      03/01/20244:41PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:BLCOBausch plus Lomb Corporation
      03/01/20244:35PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:BLCOBausch plus Lomb Corporation
      02/28/20248:12AMEdgar (US Regulatory)Form 8-K - Current reportNYSE:BLCOBausch plus Lomb Corporation
      02/28/20248:00AMBusiness WireBausch + Lomb Announces Appointment of Karen L. Ling to Board of DirectorsNYSE:BLCOBausch plus Lomb Corporation
      02/21/20247:00AMEdgar (US Regulatory)Form 8-K - Current reportNYSE:BLCOBausch plus Lomb Corporation
      02/21/20247:00AMGlobeNewswire Inc.Emergent BioSolutions Appoints Industry Leader Joseph C. Papa as New President and CEONYSE:BLCOBausch plus Lomb Corporation
      02/21/20246:58AMBusiness WireBausch + Lomb Announces Fourth-Quarter and Full-Year 2023 Results and Provides 2024 GuidanceNYSE:BLCOBausch plus Lomb Corporation
      02/05/202412:00PMBusiness WireBausch + Lomb Will Release Fourth-Quarter and Full-Year 2023 Financial Results on February 21NYSE:BLCOBausch plus Lomb Corporation
      01/08/20246:59AMBusiness WireBausch + Lomb Receives FDA Approval for TENEO™ Excimer Laser Platform for Myopia and Myopic Astigmatism LASIK Vision Correction SurgeryNYSE:BLCOBausch plus Lomb Corporation
      01/03/20244:39PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:BLCOBausch plus Lomb Corporation
      01/03/20249:00AMBusiness WireBausch + Lomb to Participate in the 42nd Annual J.P. Morgan Healthcare ConferenceNYSE:BLCOBausch plus Lomb Corporation
      11/15/20236:59AMBusiness WireBausch + Lomb Reports More Than 76 Million Units of Contact Lenses, Lens Care and Eye Care Materials Collected Through ONE By ONE and Biotrue® Eye Care Recycling ProgramsNYSE:BLCOBausch plus Lomb Corporation
      11/13/20234:47PMEdgar (US Regulatory)Form 8-K/A - Current report: [Amend]NYSE:BLCOBausch plus Lomb Corporation
      11/07/20235:00PMEdgar (US Regulatory)Form 8-K/A - Current report: [Amend]NYSE:BLCOBausch plus Lomb Corporation
      11/01/20235:03PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NYSE:BLCOBausch plus Lomb Corporation
      11/01/20237:02AMEdgar (US Regulatory)Form 8-K - Current reportNYSE:BLCOBausch plus Lomb Corporation
      11/01/20236:58AMBusiness WireBausch + Lomb Announces Third-Quarter 2023 Results and Raises Full-Year 2023 GuidanceNYSE:BLCOBausch plus Lomb Corporation
      10/26/20236:59AMBusiness WireBausch + Lomb Will Present New Scientific Data and Analyses at American Academy of Ophthalmology Annual MeetingNYSE:BLCOBausch plus Lomb Corporation
      10/16/202312:00PMBusiness WireBausch + Lomb Will Release Third-Quarter 2023 Financial Results on November 1NYSE:BLCOBausch plus Lomb Corporation
       Showing the most relevant articles for your search:NYSE:BLCO